Funding Rounds
Apollo Therapeutics Series C (2024, $33M)
Apollo TherapeuticsPortfolio of pharmaceutical research and discovery.
Summary
Stage: Series C
Raised Amount: $33.50M
Raised Date: 2024-02-01
Stage: Series C
Raised Amount: $33.50M
Raised Date: 2024-02-01
